Copy Link Print Information

Dacarbazine citrate

(Synonyms: Imidazole Carboxamide citrate)
26 Cited Publications
Customer Review

Based on 26 publication(s) in Google Scholar

Dacarbazine citrate is a cell cycle nonspecific antineoplastic alkylating agent. Dacarbazine citrate inhibits T and B lymphoblastic response, with IC50 values of 50 and 10 μg/mL, respectively. Dacarbazine Citrate can be used for the research of apoptosis and various cancers such as metastatic malignant melanoma.

For research use only. We do not sell to patients.

  • CAS No.: 64038-56-8
  • Formula: C12H18N6O8
  • Molecular Weight:374.31
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Dacarbazine citrate Chemical Structure
    Dacarbazine citrate Chemical Structure
  • Experimental Validation Results for Dacarbazine citrate
  • Experimental Validation Results for Dacarbazine citrate
  • Experimental Validation Results for Dacarbazine citrate
  • Experimental Validation Results for Dacarbazine citrate
  • Experimental Validation Results for Dacarbazine citrate
CAS No.: 64038-56-8
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Dacarbazine citrate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Dacarbazine citrate

More
Customer Validation & Images
In Vivo Efficacy StudyHistological Imaging/StainingCell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • Histological Imaging/Staining

All Antibiotic Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Dacarbazine citrate Chemical Structure
    Dacarbazine citrate Chemical Structure
    1/16
  • 1/16

    Dacarbazine citrate purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 9;16(1):268. [Abstract]

    Customer Validation
     Dacarbazine (20 mg/kg; i.p.; 20 d) reduced tumor growth rates and tumor sizes of melanoma xenograft mice.

  • 1/16

    Dacarbazine citrate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Dec;11(48):e2408707. [Abstract]

    Customer Validation
     Dacarbazine (DTIC) (500 µM; 72 h) reduced the diameter and metabolic activity of MCTs except monoculture tumoroids, especially the triples and quadruples, resulting in a decrease of approximately 32% and 28% in relative diameter, respectively, and caused a high number of apoptotic cells to detach from the main structure.

  • 1/16

    Dacarbazine citrate purchased from MedChemExpress. Usage Cited in: Nature. 2023 Jun;618(7964):374-382. [Abstract]

    Customer Validation
     Dacarbazine (60 mg/kg; i.p.; every other day for 8 d) significantly reduced red blood cell (RBC), reticulocyte (RET), and hemoglobin (HGB) counts in PBS- or B16F10-CL-EVP-educated mice.

  • 1/16

    Dacarbazine citrate purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2023 Oct 19;21(1):383. [Abstract]

    Customer Validation
     Dacarbazine (DAC) (5 mg/kg; i.v.; once every three days for 3 times) significantly inhibited the growth of subcutaneous B16F10 melanoma xenografts in C57BL/6 mice.

  • 1/16

    Dacarbazine citrate purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2023 Oct 19;21(1):383. [Abstract]

    Customer Validation
     H&E staining of tumors in each group at the end of treatment. The results showed that Dacarbazine (DAC) (5 mg/kg; i.v.; once every three days for 3 times) caused significant cell necrosis and nucleopaenia in tumors of B16F10 tumor-bearing mice. Scale bar, 100 μm.

  • Dacarbazine citrate